Therapeutic approach and management algorithms in medication-related osteonecrosis of the jaw (MONJ): recommendations of a multidisciplinary group of experts-Reference-Cited by-同舟云学术

Therapeutic approach and management algorithms in medication-related osteonecrosis of the jaw (MONJ): recommendations of a multidisciplinary group of experts

Published:2020-07-04 Issue:1 Volume:15 Page:
ISSN:1862-3522
Container-title:Archives of Osteoporosis
language:en
Short-container-title:Arch Osteoporos

Author:

Chalem Monique,Medina Adriana^ORCID,Sarmiento Ana Karina,Gonzalez Deyanira,Olarte Carlos,Pinilla Edgar,Paz Jorge,Casas Noemi,Vega Maria Paula,Diaz Edna

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11657-020-00761-0.pdf

Reference100 articles.

1. Consensus Development Conference (1991) Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 90(1):107–110

2. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA. 285(3):320–323

3. Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 1103(2A):12S–17S discussion 17S-19S

4. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733

5. Saad F, Brown JE, Van Poznak C et al (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341–1347

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats;Frontiers in Veterinary Science;2024-08-23

2. Awareness and practice of dentists in gulf cooperation council countries regarding medication-related osteonecrosis of the jaw – A web-based survey;Journal of Dental Sciences;2023-10

3. Bone-modifying agents for non–small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review;Seminars in Oncology;2023-06

4. Medication-Related Osteonecrosis: Why the Jawbone?;Dentistry Journal;2023-04-23

5. Osteonecrosis of the jaws in patients under osteoporosis treatment: a nine-year experience report;Archives of Endocrinology and Metabolism;2023